Propofol, amobarbital… is it the substance that matters, or the question about the role of the Wada test in brain tumor patients?
Contributeurs/tricesSchaller, Karl Lothard
Publié dansWorld neurosurgery, vol. 75, no. 3-4, p. 428-430
Date de publication2011
Mots-clés
- Amobarbital/adverse effects/diagnostic use
- Anesthesia, Intravenous
- Anesthetics, Intravenous/adverse effects/diagnostic use
- Brain Neoplasms/surgery
- Epilepsy/diagnosis/surgery
- Hemispherectomy
- Humans
- Hypnotics and Sedatives/adverse effects/diagnostic use
- Language
- Neuropsychological Tests
- Neurosurgical Procedures
- Postoperative Complications/diagnosis
- Predictive Value of Tests
- Prognosis
- Propofol/adverse effects/diagnostic use
- Speech/physiology
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
SCHALLER, Karl Lothard. Propofol, amobarbital… is it the substance that matters, or the question about the role of the Wada test in brain tumor patients? In: World neurosurgery, 2011, vol. 75, n° 3-4, p. 428–430. doi: 10.1016/j.wneu.2010.11.037
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:46419
- DOI : 10.1016/j.wneu.2010.11.037
- PMID : 21600484
ISSN du journal1878-8750
